Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Cash from Financing Activities (2024 - 2025)

Incannex Healthcare (IXHL) has disclosed Cash from Financing Activities for 2 consecutive years, with $927000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 77.4% to $927000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $85.4 million through Dec 2025, changed N/A year-over-year, with the annual reading at $21.4 million for FY2025, N/A changed from the prior year.
  • Cash from Financing Activities hit $927000.0 in Q4 2025 for Incannex Healthcare, down from $67.2 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $67.2 million in Q3 2025 to a low of -$52000.0 in Q3 2024.